ARCHIVES

T-Cell Vaccines Cut Time To Protective Immunity

This article is from The Cancer Letter archive.

Vol. 28 No. 11 | November 25, 2005

Download PDF Visit The Full Archive

Related Articles

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

August 29, 2014

Funding opportunities listed.

November 12, 2004

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

In Brief: National Patient Advocates Foundation Formed To Seek Health Insurance Reform

November 15, 1996

FDA Orders More Changes In ESA Label,

August 8, 2008

Funding Opportunities

September 20, 2002